Cardiac Tumour: Symptoms, Causes, Diagnosis and Treatment
Table of Contents
Key takeaways
- A cardiac tumour is an abnormal growth in the heart muscle, chambers, valves, lining or nearby pericardium.
- Primary heart tumours are rare; metastatic tumours that spread from another cancer are more common than tumours that start in the heart.
- Symptoms can mimic other heart or lung conditions, including breathlessness, chest discomfort, palpitations, fainting, stroke-like symptoms or signs of heart failure.
- Diagnosis usually relies on echocardiography plus cardiac MRI, CT or specialist imaging; biopsy is considered only when the result will guide management and can be done safely.
- Treatment depends on tumour type, location and overall health, and may include monitoring, surgery, oncology treatment, symptom control or palliative care.
Overview
A cardiac tumour is a growth found in the heart or the tissues around it. The term includes benign tumours, malignant tumours that start in the heart, and cancers that have spread to the heart from somewhere else. Although the word tumour can be frightening, not every cardiac tumour is cancer. The concern is that even a benign growth can interfere with blood flow, valves, rhythm or the electrical system because the heart has very little spare space.
Primary cardiac tumours are rare. Myxoma is the best-known benign adult primary tumour and often arises in the left atrium. Other benign tumours include papillary fibroelastoma, lipoma, fibroma and rhabdomyoma. Malignant primary cardiac tumours, such as cardiac sarcoma, are uncommon but can be aggressive. Secondary or metastatic involvement can occur with cancers such as lung cancer, breast cancer, melanoma, lymphoma or kidney cancer.
For women, the context matters. Symptoms such as breathlessness, fatigue, palpitations and chest discomfort may be attributed to stress, anaemia, menopause or anxiety, but persistent or progressive symptoms deserve assessment. A cardiac tumour is rare, yet the same symptoms can also point to common conditions that need treatment.
Types of cardiac tumour
Benign primary tumours do not spread like cancer, but they can still be clinically serious. A myxoma may intermittently block blood flow through a valve or shed fragments that travel as emboli. Papillary fibroelastomas are often attached to valves and may be associated with embolic events. Rhabdomyomas are more often seen in children and may be linked with tuberous sclerosis.
Malignant primary tumours start in heart tissue. Cardiac sarcomas can grow into chambers, invade nearby structures and cause symptoms by obstruction, arrhythmia, pericardial effusion or heart failure. They need coordinated cardiology, cardiothoracic surgery and oncology assessment.
Secondary cardiac tumours are cancers that involve the heart after starting elsewhere. They may reach the heart through the bloodstream, lymphatic system, direct extension from nearby tissue or spread to the pericardium. Management is usually guided by the primary cancer type, extent of disease and the symptom burden.
Symptoms
Some cardiac tumours are found incidentally during imaging. Others cause symptoms because they obstruct blood flow, irritate the heart rhythm, damage valves, trigger inflammation or shed emboli. Possible symptoms include breathlessness, chest pain or pressure, palpitations, dizziness, fainting, ankle swelling, fatigue, fever, unintentional weight loss or a new heart murmur.
Embolic symptoms can include stroke-like weakness, facial drooping, speech difficulty, sudden visual changes, limb pain or signs of reduced blood supply. Pericardial involvement may cause fluid around the heart, chest discomfort that changes with position, or, rarely, cardiac tamponade. Because these presentations overlap with many other conditions, imaging and specialist assessment are essential.
Causes and risk factors
For many primary cardiac tumours, the exact cause is not known. Some occur sporadically. Others are associated with inherited syndromes or genetic conditions, such as Carney complex for recurrent myxomas or tuberous sclerosis for rhabdomyomas. Previous cancer history is relevant because metastatic disease is more common than a new primary heart cancer.
Radiotherapy to the chest and some cancer treatments may increase the need for long-term heart monitoring, although this is separate from saying they directly cause every cardiac tumour. Clinicians consider the whole picture: age, cancer history, inherited conditions, symptoms, imaging appearance and how quickly the mass is changing.
Diagnosis
Assessment usually begins with clinical history, examination, ECG and echocardiography. Echocardiography can show a mass, its movement, attachment site, effect on valves and whether there is obstruction or fluid around the heart. Transoesophageal echocardiography may give clearer detail for atrial or valve lesions.
Cardiac MRI is often valuable because it can define tissue characteristics, invasion and relationship to nearby structures. CT can help assess calcification, chest anatomy or cancer spread. PET-CT may be used in oncology pathways. Blood tests can assess anaemia, inflammation, cardiac strain or other causes of symptoms, but they do not replace imaging.
Biopsy is not always needed. If imaging strongly suggests a removable benign tumour, surgery may provide both treatment and tissue diagnosis. If cancer is suspected, biopsy decisions are made carefully because the heart is a high-risk site and the result must change the treatment plan.
Treatment and management
Treatment is individualised. A benign tumour causing obstruction, embolic risk or significant symptoms is often considered for surgical removal if the person is fit enough and anatomy allows. Surgery may involve removing the mass, repairing the attachment site and correcting valve damage. Some small, stable lesions may be monitored with scheduled imaging if the risk of intervention outweighs the likely benefit.
Malignant tumours need multidisciplinary care. Options may include surgery when complete or useful partial removal is feasible, chemotherapy, radiotherapy, targeted oncology treatment, symptom-directed cardiac care or palliative support. When the tumour is metastatic, treatment usually focuses on the original cancer and on relieving cardiac complications such as arrhythmia, effusion, obstruction or heart failure.
Medicines may help manage rhythm disturbances, fluid overload, pain or clot risk, but they are not a substitute for defining the tumour type and treatment aim. Suitability for any intervention is confirmed after specialist consultation.
Living with follow-up
There are no proven home remedies that remove a cardiac tumour. Useful self-care means attending imaging appointments, reporting new symptoms promptly, taking prescribed medicines correctly and keeping a written record of scans, operations, pathology results and oncology treatment. People with a suspected inherited syndrome may be offered genetic counselling and family assessment.
Emotional support is also part of care. Uncertainty around a rare heart mass can be distressing, particularly if cancer is already part of the picture. A named cardiology or oncology contact can help clarify who to call if symptoms change.
When to seek medical advice
Seek prompt medical advice for new breathlessness, palpitations, fainting, unexplained chest discomfort, swelling, persistent fever, unexplained weight loss or symptoms that worsen when lying flat. Use NHS 111 for urgent advice if symptoms are concerning and you are unsure where to go.
Call 999 for severe chest pain, severe breathlessness, collapse, signs of stroke, coughing blood, confusion or a rapidly worsening known heart condition.
Sources
- Cleveland Clinic: Heart tumour: my.clevelandclinic.org guidance page link unavailable during validation (my.clevelandclinic.org guidance page, link unavailable during validation)
Relevance: Provides clinically reviewed overview of heart tumour types, symptoms, diagnosis and treatment. - PubMed Central: Cardiac tumours review: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715088/
Relevance: Reviews classification, imaging and clinical behaviour of primary and secondary cardiac tumours. - NHS: Cancer symptoms: https://www.nhs.uk/conditions/cancer/symptoms/
Relevance: Supports cautious UK-facing advice on persistent symptoms that need medical assessment. - American Heart Association journal review via PubMed: Cardiac masses and tumours: https://pubmed.ncbi.nlm.nih.gov/31068091/
Relevance: Supports the need for multimodality imaging and specialist interpretation of cardiac masses.
Disclaimer
Educational only. Results vary. Not a cure.
Details that must be confirmed before publishing: confirm whether WHM prefers UK spelling in the live slug as cardiac-tumour or keeps the imported US spelling for redirects.